Cargando…

Correction to: Therapeutic novelties in migraine: new drugs, new hope?

Detalles Bibliográficos
Autores principales:	Do, Thien Phu, Guo, Song, Ashina, Messoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734468/ https://www.ncbi.nlm.nih.gov/pubmed/31100999 http://dx.doi.org/10.1186/s10194-019-1013-0

Ejemplares similares

Therapeutic novelties in migraine: new drugs, new hope?
por: Do, Thien Phu, et al.
Publicado: (2019)

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Correction: PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
por: Guo, Song, et al.
Publicado: (2023)

Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
por: Do, Thien Phu, et al.
Publicado: (2023)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
por: Martelletti, Paolo, et al.
Publicado: (2019)

Cluster headache – The worst possible pain on YouTube
por: Chaudhry, Basit Ali, et al.
Publicado: (2022)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Correction: Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study
por: Amin, Faisal Mohammad, et al.
Publicado: (2023)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
por: Cullum, Christopher Kjaer, et al.
Publicado: (2022)

The changing faces of migraine
por: Martelletti, Paolo, et al.
Publicado: (2019)

One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey
por: Do, Thien Phu, et al.
Publicado: (2022)

Characterizing healthcare utilization patterns in a Danish population with headache: results from the nationwide headache in Denmark (HINDER) panel
por: Do, Thien Phu, et al.
Publicado: (2023)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2021)

Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
por: Ashina, Håkan, et al.
Publicado: (2022)

Correction to: Ultra-high field MR angiography in human migraine models: a 3.0 T/7.0 T comparison study
por: Christensen, Casper Emil, et al.
Publicado: (2019)

Correction: Novelty Enhances Visual Perception
por: Schomaker, Judith, et al.
Publicado: (2013)

Correction: Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark
por: Do, Thien Phu, et al.
Publicado: (2022)

The chronobiology of migraine: a systematic review
por: Poulsen, Amanda Holmen, et al.
Publicado: (2021)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

Brain barriers and their potential role in migraine pathophysiology
por: Wiggers, Astrid, et al.
Publicado: (2022)

Locating Organizations and Their Methods in Registrations of Clinical Migraine Trials: Analysis of ClinicalTrials.gov
por: Zhang, Pengfei, et al.
Publicado: (2021)

Imaging the inflammatory phenotype in migraine
por: Christensen, Rune Häckert, et al.
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2022)

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
por: Ashina, Messoud, et al.
Publicado: (2021)

PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
por: Guo, Song, et al.
Publicado: (2022)

Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review
por: Bahtiri, Lionesa, et al.
Publicado: (2023)

Therapeutical Novelties
Publicado: (1854)

Migraine and risk of hemorrhagic stroke: a study based on data from general practice
por: Gaist, David, et al.
Publicado: (2014)

Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
por: Thuraiaiyah, Janu, et al.
Publicado: (2022)

The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
por: Karlsson, William Kristian, et al.
Publicado: (2023)

Correction to: Increase in excitability of hippocampal neurons during novelty-induced hyperlocomotion in dopamine-deficient mice
por: Fujita, Masayo, et al.
Publicado: (2021)

Calcitonin gene-related peptide causes migraine aura
por: Al-Khazali, Haidar M., et al.
Publicado: (2023)

Detecting New Physics as novelty
por: Liu, Tao
Publicado: (2020)

Correction: Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials
por: Christensen, Casper Emil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4gl7m5s0v7nivmk8rgc74qrqmn